Oncologix Tech Inc.: 10-Q/A filed 2014-02-10

Name: Oncologix Tech Inc.: 10-Q/A filed 2014-02-10
Creator: Oncologix Tech Inc.
License: https://creativecommons.org/licenses/by/4.0/

What Oncologix Tech Inc. reported in its quarterly report amendment filed 2014-02-10 (fiscal Q1 2014): 26 published measures, 48 facts as tagged in accession 0001471242-14-000050.

This is an amendment. Values here are as tagged in the amendment; the original filing has its own page.

This filing

Form: 10-Q/A (quarterly report amendment)
Filed: 2014-02-10
Fiscal period: fiscal Q1 2014
Accession: 0001471242-14-000050 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All Oncologix Tech Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2013-11-30	2,066,408	USD
At 2013-08-31	2,033,850	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2013-11-30	2,445,165	USD
At 2013-08-31	2,394,595	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2013-11-30	-378,757	USD
At 2013-08-31	-360,745	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2013-11-30	94,143	USD
At 2013-08-31	39,456	USD
At 2012-11-30	6,260	USD
At 2012-08-31	1,931	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2013-09-01 to 2013-11-30	-189,829	USD	91
2012-09-01 to 2012-11-30	-46,944	USD	91

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2013-09-01 to 2013-11-30	-31,483	USD	91
2012-09-01 to 2012-11-30	-29,661	USD	91

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2013-09-01 to 2013-11-30	-416	USD	91

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2013-09-01 to 2013-11-30	724,632	USD	91

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2013-09-01 to 2013-11-30	416	USD	91

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2013-11-30	-47,248,181	USD
At 2013-08-31	-58,992,296	USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2013-11-30	46,279	USD
At 2013-08-31	78,533	USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2013-09-01 to 2013-11-30	-52,735	USD	91
2012-09-01 to 2012-11-30	-43,804	USD	91

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2013-11-30	284,564	USD
At 2013-08-31	218,222	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2013-11-30	1,646,427	USD
At 2013-08-31	1,583,095	USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

Period	Value	Unit	Days
At 2013-11-30	1,696,425	USD
At 2013-08-31	1,696,425	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2013-09-01 to 2013-11-30	282,812	USD	91
2012-09-01 to 2012-11-30	43,804	USD	91

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2013-09-01 to 2013-11-30	230,077	USD	91

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

Period	Value	Unit	Days
2013-09-01 to 2013-11-30	494,555	USD	91

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2013-11-30	81,087,422	shares
At 2013-08-31	74,587,422	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2013-11-30	46,788,149	USD
At 2013-08-31	58,560,265	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2013-11-30	15,489	USD
At 2013-08-31	11,820	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2013-11-30	31,368	USD
At 2013-08-31	39,176	USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2013-09-01 to 2013-11-30	-189,829	USD	91
2012-09-01 to 2012-11-30	-46,940	USD	91

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2013-09-01 to 2013-11-30	277,360	USD	91
2012-09-01 to 2012-11-30	43,714	USD	91

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2013-09-01 to 2013-11-30	10,000	USD	91
2012-09-01 to 2012-11-30	20,000	USD	91

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2013-09-01 to 2013-11-30	-19,463	USD	91

Inspect the source

Entity: Oncologix Tech Inc. / CIK 0000799694
Captured: 2026-09-23 02:40 UTC
SEC response SHA-256: acc83506e9d3f32d85d91503a2bd087a712fbc014fe7429b835fa6f76c6de48d

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000799694.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))